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Renal structure and hypertension in autosomal dominant polycystic
kidney disease. Hypertension has been reported to occur in 50 to 75
percent of subjects with autosomal dominant polycystic kidney disease
(ADPKD) prior to the onset of marked renal insufficiency but concur-
rent with cystic deformation of the renal parenchyma. The present
study was undertaken to examine whether the renal structural abnor-
malities are greater in hypertensive (HBP) versus normotensive (NBP)
male and female patients with ADPKD who were matched within
gender groups for age, body surface area, serum creatinine concentra-
tion (males HBP 1.2 0.02 vs. NBP 1.1 0.03 mg/dl. NS: females HBP
0.9 0.03 vs. NBP 0.9 0.02 mg/dl, NS) and creatinine clearance
(males HBP 100 3 vs. NBP 108 3 ml/min/l.73 m2. NS: females HBP
97 3 vs. NBP 96 2 ml/niin/l.73 m2. NS). Renal volume was
significantly greater in the HBP compared to the NBP group (males
HBP 624 47 vs. NBP 390 43 cm3, P < 0.0005: females HBP 466
32 vs. NBP 338 24 cm3, P < 0.002). Since increased renal volume is
due to increased cysts, the results indicate that the early high incidence
of hypertension in ADPKD correlates with the renal structural abnor-
malities in this disorder.
An early and high incidence of hypertension has been well
documented in autosomal dominant polycystic kidney disease
(ADPKD), often occurring prior to a decrease in creatinine
clearance [1—101. This hypertension in ADPKD may contribute
to the high cardiovascular mortality in these patients [II] and
also may accelerate the rate of progression of renal insufficiency
[11, 12]. The pathogenesis of the hypertension associated with
ADPKD, however, has not been clearly established.
Since ADPKD is a systemic disease with several extrarenal
abnormalities including hepatic cysts [3]. intracranial aneu-
rysirts [13], mitral valve prolapse [14], and intestinal diverticu-
litis [15], the high incidence of hypertension in these patients
could reside in some extrarenal and/or intrarenal pathogenetic
factors.
An intrarenal pathogenesis of ADPKD hypertension has been
suggested by the observation that renal cyst decompression has
been associated with a decrease in blood pressure [16, 17].
Long-term persistence of this hypotensive effect of renal cyst
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decompression in ADPKD has, however, not been docu-
mented, perhaps because of renal fluid reaccumulation in
decompressed cysts or enlargement of other renal cysts.
The present study was undertaken to explore further the
potential role of renal cystic enlargement in initiating hyperten-
sion in ADPKD. The results supported this hypothesis. In the
sex, age, body surface area, and creatinine clearance-matched
normotensive and hypertensive patients with ADPKD, the
hypertensive patients exhibited significantly larger renal vol-
umes reflecting greater cystic involvement.
Methods
One hundred and forty-seven subjects with ADPKD were
studied at the Clinical Research Center at the University of
Colorado Health Sciences Center from July 1985 to November
1989. All subjects underwent a detailed formalized interview
including a complete history and physical examination with
determination of blood pressure in all subjects. Hypertension
was defined as diastolic pressure greater than 90 mm Hg, a
systolic pressure greater than 150 mm Hg in the sitting position,
or a known history of hypertension on therapy. Mean arterial
pressure (MAP) is reported as diastolic pressure plus one third
of the pulse pressure. Study subjects were between the ages of
16 and 45 years with a serum creatinine concentration less than
1.5 mgldl and creatinine clearance between 75 and 150 mI/mini
1.73 m2. Body surface area (BSA) was less than 2.6 m2 for
males and less than 2.2 m2 for females. The hypertensive and
normotensive groups did not differ in mean age, body surface
area, serum creatinine concentration or creatinine clearance.
A complete abdominal ultrasonogram was performed on all
subjects utilizing a high resolution real-time scanner (Acuson or
ATL with a 35 or 5 mmHz transducer) and a conventional static
scanner (Picker 802). These methods detect cysts greater than 2
mm in diameter. Images from the static scan were used to
measure renal dimensions. Renal volume was calculated using
the following formula for a modified ellipse: 4/3 ir (length/2)
(anterior-posterior diameter/4 + width/4)2. Mean renal volume
was calculated from both kidneys. Subjects were considered to
have ADPKD if there were bilateral renal cysts totalling five or
more.
Serum creatinine concentrations were measured in all pa-
tients while on an ad lib diet. Two consecutive 24-hour urine
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collections were obtained for creatinine; creatinine clearances
were calculated and corrected for body surface area. All
laboratory determinations were performed by the Clinical Re-
search Laboratory at the University of Colorado Health Sci-
ences Center.
Means of continuous variables were compared using the two
sample t-test for unequal sample sizes and unequal variances
when applicable. Chi-square tests were used to investigate the
relationships among categorical variables. All variables are
presented as mean one standard error. Tests of significance
are executed at a significance level of 0.05, however, significant
P values are also provided.
Results
Sixty-four male and eighty-three female subjects comprised
the study population. Forty-two of the male subjects were
hypertensive (HBP) (66%) and twenty-two were normotensive
(NBP) (34%). Thirty-four of the female subjects were HBP
(41%) and forty-nine were NBP (59%). The frequency of
hypertension was significantly greater in the males than in the
females in this population (P < 0.003).
Fifty-nine percent of the HBP group (45 of 76) were diag-
nosed with hypertension prior to the study and were taking
antihypertensive medications. However, 49% of this group on
medication were still hypertensive by the study criteria (22 of
45) with a mean MAP of 114 mm Hg. An additional seven
percent of the HBP group (5 of 76) were diagnosed with
hypertension prior to the study but were not taking medication
and all were hypertensive at the time of the study with a mean
MAP of 114 mm Hg. Thirty-four percent of the HBP group (26
of 76) were not aware they were hypertensive prior to the study
(mean MAP 112 mm Hg). The mean age of onset of hyperten-
sion was 27 years (males 27 I vs. females 26 1 years, NS).
Age (HBP 32.3 0.9 vs. NBP 31.1 0.9 years, NS), BSA
(HBP 1.76 0.03 vs. NBP 1.69 0.03 m2, NS), serum
creatinine (HBP 0.9 0.03 vs. NBP 0.9 0,02 mgldl, NS), and
creatinine clearance (HBP 97 3 vs. NBP 96 2 mI/mm/I .73
m2, NS) were not different between the hypertensive and
normotensive ADPKD females. Similarly, age (HBP 32.7 1.1
vs. NBP 29.6 1.7 years, NS), BSA (HBP 2.03 0.03 vs. NBP
2.00 0.04 m2, NS), serum creatinine (HBP 1.2 0.02 vs. NBP
1.1 0.03 mg/dl, NS), and creatinine clearance (HBP 100 3
vs. NBP 108 3 ml/min/l.73 m2, NS) were similar in hyper-
tensive and normotensive ADPKD males (Table 1).
MAP was higher in hypertensive than normotensive patients
of both genders (Table 1). MAP was significantly higher in the
men compared to the women in both the HBP (P < 0.02) and
the NBP (P <0.005) groups. Both HBP and NBP groups had a
significant increase in MAP after changing from supine to
upright position (HBP 10.5 1.0 mm Hg, P < 0.0001; NBP 9.9
1.0mm Hg, P <0.0001). However, this change in MAP with
the assumption of an upright posture was not different between
HBP and NBP groups.
Mean renal volume was significantly greater in the HBP males
and females versus the NBP males and females respectively
(males HBP 624 47 vs. NBP 390 43 cm3, P < 0.0005; females
HBP 466 32 vs. NBP 338 24 cm3, P < 0.002) (Fig. 1).
Table 1. Subject characteristics of HBP and NBP groups
Male Female
Age years
Hypertensive 32.7 1.1 32.3 0.9
Normotensive 29.6 1.7 31.1 0.9
P value NS NS
BSA m2
Hypertensive 2.03 0.03 1.76 .03
Normotensive 2.00 0.04 1.69 .03
P value NS NS
Creatinine clearance
m!/minll.73 m2
Hypertensive 100 3 97 3
Normotensive 108 3 96 2
P value NS NS
Scr mg/dl
Hypertensive 1.2 0.02 0.9 0.03
Normotensive 1.1 0.03 0.9 0.02
P value NS NS
MAP mm Hg
Hypertensive 112 2 105 2
Normotensive 99 2 94 I
P value 0.0001 0.0001
Discussion
Hypertension is a common occurrence in ADPKD prior to
the onset of marked renal insufficiency [1—10]. In addition,
marked structural deformation usually occurs in ADPKD prior
to azotemia [3]. Since less pronounced renal structural abnor-
malities than those observed in ADPKD have been considered
pathogenetic in some forms of hypertension [18—22], it is
reasonable to suggest a relationship between structural defor-
mation and hypertension early in the course of ADPKD. This
was the major hypothesis examined in the present study.
In order to examine this hypothesis in a study population it
was important to consider other factors known to alter blood
pressures. Gender is an important determinant of blood pres-
sure, with essential hypertension being more common in males
than in premenopausal females [23]. Indeed in our population
hypertension was more common in males than in females.
Hence for analysis, the groups were separated by gender. As
BSA also can affect blood pressure [24], the study populations
were matched for this variable. Finally, given the role of
impairment of renal function in hypertension, the study groups
were matched for renal function as measured by serum creati-
nine and creatinine clearance and renal function was within the
normal range.
In the present study, in both male and female ADPKD
patients, hypertension was associated with greater renal struc-
tural abnormalities at comparable body surface areas and renal
function. Specifically, the hypertensive ADPKD patients exhib-
ited greater renal volumes. These results, therefore, may help
explain the observation of Bennett et al [16] and Frang, Czval-
inga and Polyak [17] that renal cyst decompression is associated
with a decrease in systemic blood pressure. The present results
are also compatible with the earlier findings of Milutinovic et al,
which were not controlled for age, BSA, or gender [101, that
patients with kidneys larger than 15 cm were more likely to be
hypertensive.
The mechanism(s) by which renal cysts may initiate hyper-
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Fig. 1. Rena! volume in HBP and NBP
ADPKD subjects separated by gender. The
bars are means 1 standard error of the
mean. Symbols are: (•) HBP; (0) NBP.
Angiographic studies have shown attenuation of peripheral
renal vasculature by renal cysts in patients with ADPKD [25,
26]. On the other hand, hormonal evidence of renal ischemia
has been less evident. Specifically, plasma renin activity (PRA)
has not been found to be consistently elevated in patients with
ADPKD [5, 8]. It should be noted, however, that bilateral renal
ischemia secondary to cyst enlargement in ADPKD may mimic
bilateral renal artery stenosis which also is not consistently
associated with an increase in PRA [27]. Moreover, recent
preliminary data demonstrated that PRA and plasma aldoste-
rone were significantly increased in hypertensive patients with
ADPKD as compared to matched patients with essential hyper-
tension, both before and after converting enzyme inhibition
[281. Thus, the early initiation of hypertension in ADPKD may
relate to bilateral renal ischemia secondary to cyst alteration of
renal vasculature. Further studies will be necessary to establish
this pathogenetic mechanism by which increasing cystic in-
volvement results in hypertension in ADPKD but activation of
the renin-angiotensin-aldosterone system appears to be in-
volved.
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